Core Viewpoint - The article discusses the advancements in cancer immunotherapy through the use of generative AI to design artificial T-cell receptors (TCRs) that can specifically bind to pMHC complexes, overcoming the limitations of natural TCRs and enabling more precise targeting of tumor antigens [4][21][23]. Group 1: Traditional TCR Methods - Traditional methods for utilizing TCR in cancer immunotherapy involve isolating T cells from patients, either through tumor-infiltrating lymphocytes (TILs) or expanding T cells from an initial T cell library, which is technically challenging and labor-intensive [3]. - Natural TCRs often have poor affinity for tumor antigens, making it difficult to achieve effective immunotherapy [3]. Group 2: Generative AI Research - On July 24, 2025, three research papers published in the journal Science demonstrated the use of generative AI to design artificial TCRs that can bind with high specificity to pMHC complexes, thus enhancing the precision of tumor antigen targeting [4][5][21]. - The research teams involved include those from the University of Washington, Technical University of Denmark, and Stanford University [5]. Group 3: Protein Design and Functionality - The David Baker/Liu Bingxu team developed a computational method to enhance the immune system's ability to recognize and destroy cells carrying less detectable disease markers by designing proteins that specifically recognize target pMHC complexes [10]. - The designed proteins were tested against 11 different pMHC targets, including fragments from HIV and cancer-related mutations, with 8 of them successfully activating immune cells [13]. - The study confirmed that the designed proteins only bind to their specific targets, achieving atomic-level precision in construction [14]. Group 4: Rapid and Scalable Design Process - The design process demonstrated high adaptability, allowing the creation of new versions of binding proteins for different tumor and viral peptide targets in less than a week [16]. - This digital approach contrasts with traditional drug development methods, significantly shortening the drug development cycle and reducing complexity, while paving the way for more personalized therapies [16]. Group 5: Future Directions and Company Formation - The lead author, Dr. Liu Bingxu, indicated plans to establish a company to translate these research findings into therapies that can benefit patients [18]. - The research highlights the potential for artificial TCRs to revolutionize diagnostic tools and immunotherapies, particularly for diseases that currently lack effective treatments [22][23].

Core Viewpoint - The article discusses the successful application of CAR-T cell therapy in treating refractory autoimmune encephalitis associated with DAGLA antibodies, highlighting its potential as a novel treatment option for patients unresponsive to standard therapies [4][13]. Group 1: Disease Overview - Autoimmune encephalitis is a severe brain condition where the immune system attacks the brain, leading to symptoms such as memory loss, confusion, behavioral changes, and severe seizures [2]. Group 2: CAR-T Cell Therapy - CAR-T cell therapy targets specific immune cells (B cells) and shows promise in treating autoimmune diseases, including those causing brain inflammation [3]. - The therapy involves a single intravenous infusion of fully human second-generation CAR-T cells targeting CD19 [8]. Group 3: Case Study - A 36-year-old male patient with refractory DAGLA antibody-associated autoimmune encephalitis underwent CAR-T cell therapy after failing multiple treatments, including corticosteroids and plasma exchange [9][10]. - Post-treatment, the patient showed significant clinical improvement, with a reduction in harmful antibodies attacking the brain [10][14]. Group 4: Research Findings - The study published in Cell journal demonstrated that CAR-T cell therapy successfully reversed refractory DAGLA antibody-associated encephalitis, with antibodies disappearing from serum and cerebrospinal fluid after treatment [4][14]. - One year after treatment, the patient continued to show sustained clinical improvement [14].

Core Viewpoint - The emergence of immunotherapy has significantly changed the landscape of cancer treatment, but resistance to immunotherapy remains a major obstacle for its broader clinical application. Recent studies indicate that gut microbiota can enhance the efficacy of immunotherapy by modulating anti-tumor immunity [2]. Group 1: Research Findings - A study published by Professor Xu Ruihua's team from Sun Yat-sen University on July 24, 2025, in the journal Cancer Cell, demonstrates that the gut bacterium Alistipes finegoldii can enhance the efficacy of immunotherapy against solid tumors [3][4]. - The research found that a higher abundance of Alistipes finegoldii is associated with improved responses to immunotherapy, particularly enhancing the efficacy of anti-PD-1 monoclonal antibodies in solid tumor models [8]. - Alistipes finegoldii activates the CXCL16-CXCR6 signaling axis to boost anti-tumor immune responses, with lipoproteins derived from Alistipes finegoldii triggering the TLR2-NF-κB-CXCL16 signaling pathway [7][8]. Group 2: Mechanism of Action - The mechanism involves lipoproteins from Alistipes finegoldii binding to Toll-like receptor 2 (TLR2), activating the NF-κB signaling pathway, which enhances the expression of CXCL16 in CCR7+ conventional dendritic cells [7]. - The released CXCL16 aids in recruiting CXCR6+ CD8+ T cells to the tumor microenvironment (TME), effectively inhibiting tumor growth [7][8]. Group 3: Implications for Treatment - Overall, the findings suggest that combining Alistipes finegoldii with immunotherapy could represent a new strategy for treating solid tumors [10].

Core Viewpoint - The article discusses recent research on the biosynthesis of salicylic acid (SA) in plants, highlighting its importance in plant defense mechanisms and its historical significance in human medicine, particularly in the development of aspirin [2][5][13]. Group 1: Research Findings - The study conducted by teams from Zhejiang University and others revealed a three-step enzymatic reaction module (BEBT-BBH-BSE) that facilitates the conversion of benzoyl-CoA to salicylic acid in rice, demonstrating that this pathway is conserved across various crops [3][8]. - The research identified three specific enzymes involved in this pathway: benzoyl-CoA:benzyl transferase (BEBT), benzyl benzoate hydroxylase (BBH), and salicylic acid benzyl ester hydrolase (BSE), which sequentially convert benzoyl-CoA into salicylic acid [6][8]. - The findings fill a significant knowledge gap in the biosynthesis of key plant defense hormones, providing a foundation for developing disease-resistant crops [8][14]. Group 2: Related Studies - Concurrently, two other studies published in Nature also focused on salicylic acid biosynthesis, confirming the conservation of the PAL synthesis pathway in seed plants and its implications for understanding disease resistance mechanisms in various plant groups [9][10]. - The research from Sichuan University and Zhejiang Normal University further elucidated the complete biosynthesis pathway of salicylic acid from phenylalanine, reinforcing the idea of its evolutionary conservation in most seed plants [10][14].

Core Insights - On July 23, 2025, a total of 26 papers were published in the prestigious journal Nature, with 11 authored by Chinese scholars, highlighting the significant contribution of Chinese researchers to global scientific discourse [2][4][6][7][10][12][15][17][19][21][23]. Group 1: Research Contributions - Research by Chen Lingling from the Chinese Academy of Sciences focused on the spatial distribution and functional organization of pre-rRNA in the nucleolus [2]. - Zhang Yuelin from Sichuan University explored a three-step biosynthesis pathway of salicylic acid from benzoyl-CoA in plants [4]. - A study by Pan Ronghui and Fan Pengxiang from Zhejiang University deciphered the biosynthesis of salicylic acid derived from phenylalanine in plants [6]. - Zhang Kewei and collaborators from Zhejiang Normal University detailed the complete biosynthesis of salicylic acid from phenylalanine in plants [7]. - Research by Yile Dai from Yale University examined humoral determinants of checkpoint immunotherapy [10]. - Zepeng Mu from Harvard Medical School investigated the effects of disease variants in CRISPR-edited single cells [12]. - Winston W. Liu from Duke University/Stanford University Medical School studied how gut sensing of microbial patterns regulates feeding [15]. - Ziliang Kang from MIT developed mechanical underwater adhesive devices for soft substrates [17]. - Arthur Zhao from the Howard Hughes Medical Institute researched how eye structure shapes neuron function in Drosophila motion vision [19]. - Zhiqian Li from UC San Diego and Yuemei Dong from Johns Hopkins University focused on driving a protective allele of the mosquito FREP1 gene to combat malaria [21]. - A review by Gao Caixia from the Chinese Academy of Sciences and Li Guotian from Huazhong Agricultural University integrated biotechnological and AI innovations for crop improvement [23].

Core Viewpoint - The article discusses a groundbreaking non-invasive neuromotor interface developed by Meta's Reality Labs, which allows users to interact with computers through wrist-worn devices that translate muscle signals into computer commands, enhancing human-computer interaction, especially in mobile scenarios [2][3][5]. Group 1: Technology Overview - The research presents a wrist-worn device that enables users to interact with computers through hand gestures, converting muscle-generated electrical signals into computer instructions without the need for personalized calibration or invasive procedures [3][5]. - The device utilizes Bluetooth communication to recognize real-time gestures, facilitating various computer interactions, including virtual navigation and text input at a speed of 20.9 words per minute, compared to an average of 36 words per minute on mobile keyboards [6]. Group 2: Research and Development - The Reality Labs team developed a highly sensitive wristband using training data from thousands of subjects, creating a generic decoding model that accurately translates user inputs without individual calibration, demonstrating performance improvements with increased model size and data [5]. - The research indicates that personalized data can further enhance the performance of the decoding model, suggesting a pathway for creating high-performance biosignal decoders with broad applications [5]. Group 3: Accessibility and Applications - This neuromotor interface offers a wearable communication method for individuals with varying physical abilities, making it suitable for further research into accessibility applications for those with mobility impairments, muscle weakness, amputations, or paralysis [8]. - To promote future research on surface electromyography (sEMG) and its applications, the team has publicly released a database containing over 100 hours of sEMG recordings from 300 subjects across three tasks [9].

Core Viewpoint - The development of the Aeneas model by Google's DeepMind aims to assist historians in analyzing and contextualizing ancient Latin inscriptions, addressing the challenges posed by incomplete texts and the vast amount of data available [3][6]. Group 1: Aeneas Model Development - The Aeneas model is a generative AI tool designed to find relationships between Roman-era Latin inscriptions and other texts, helping to determine the context of these inscriptions and predict missing parts [3][6]. - The model was trained on a merged dataset containing 176,861 inscriptions, with 5% accompanied by images, spanning from the 7th century BC to the 8th century AD [6]. Group 2: Model Functionality and Performance - Aeneas consists of three neural networks, each responsible for different tasks: repairing missing text, predicting text origins, and assessing dating [7]. - Historians found that Aeneas provided useful contextual suggestions 90% of the time, improving confidence in key tasks by 44% [7]. - The model's dating accuracy showed a margin of error of less than 13 years, compared to historians' 31 years, indicating a significant improvement in dating inscriptions [7]. Group 3: Practical Applications - Aeneas demonstrated effectiveness in analyzing altars with Latin inscriptions, identifying connections between inscriptions from the same region without prior geographical knowledge [8]. - The model successfully repaired a damaged inscription from a bronze military certificate issued by a Roman emperor, showcasing its ability to handle large datasets that are challenging for humans [10]. - Aeneas provides more logical answers based on its evidence base, contrasting with other popular AI tools that may generate random guesses [10].

Core Insights - The article emphasizes the importance of ensuring food security and sustainable agricultural development in the face of global population growth, climate change, and decreasing arable land resources [1] Group 1: Technological Innovations in Crop Improvement - A review paper published in Nature discusses the integration of multi-omics, genome editing, protein design, high-throughput phenotyping, and artificial intelligence (AI) in crop genetic improvement [2][3] - Modern omics technologies, such as genomics and metabolomics, provide unprecedented capabilities to analyze crop genetic information, revealing new loci for precise trait improvement [4] - High-throughput phenotyping (HTP) technologies utilize drones and sensors for rapid and accurate assessment of crop traits, effectively linking genotype to phenotype [4] Group 2: Genome Editing and Protein Design - Genome editing technologies, exemplified by CRISPR, enable efficient and precise modifications of crop genomes, significantly shortening breeding cycles and rapidly creating desirable traits [4] - AI-driven protein design technologies are emerging, allowing the creation of novel proteins with specific functions, which can lead to breakthroughs in disease resistance and environmental monitoring [4] Group 3: AI-Assisted Crop Design Framework - The review introduces an "AI-assisted crop design" model that integrates and analyzes multimodal big data from genomics, phenomics, environment, and management practices [19] - Breeders can set specific improvement goals, such as yield enhancement or stress resistance, while AI generates optimized breeding plans through deep learning and knowledge reasoning [19] Group 4: Challenges and Future Directions - The article discusses the challenges and future directions for the application of new technologies, highlighting the need for high-quality, standardized data for training AI models [21] - Regulatory policies for genome-edited crops are evolving towards more scientific and simplified frameworks, creating favorable conditions for the widespread application of new technologies [21]

Core Viewpoint - The article discusses a novel strategy to improve CAR-T cell therapy for osteosarcoma by utilizing cuproptosis, which enhances the efficacy of the treatment in a challenging tumor microenvironment [3][4][11]. Group 1: Osteosarcoma and Current Treatment Challenges - Osteosarcoma is a common malignant tumor with a low survival rate of approximately 15%-17% for patients receiving only surgical treatment, and a stagnated 5-year survival rate of about 60% for those undergoing combined surgery and chemotherapy over the past 30 years [1]. - Traditional chemotherapy often leads to drug resistance and tumor recurrence, highlighting the urgent need for improved treatment strategies [1]. Group 2: Novel Research Findings - A study published by a team from Southern Medical University proposes a new approach using cuproptosis to enhance CAR-T cell therapy in osteosarcoma [2]. - The research indicates that copper death can lower PD-L1 expression in osteosarcoma cells, which is positively correlated with copper death-related gene expression [8][11]. - The study developed a biocompatible nanodrug composed of tetrahedral framework nucleic acids (tFNA), elesclomol-Cu, and anti-PD-L1 antibodies to induce copper death and block the PD-1-PD-L1 signaling axis, thereby reshaping the immunosuppressive tumor microenvironment [3][9]. Group 3: Implications for CAR-T Cell Therapy - The results demonstrate that the use of this nanodrug significantly enhances CAR-T cell infiltration and anti-tumor activity in both in situ and recurrent osteosarcoma models [10]. - This research provides insights into the relationship between copper metabolism and PD-L1 expression, offering a potential universal method to improve adoptive cell therapy for solid tumors [4].

撰文丨王聪 编辑丨王多鱼 排版丨水成文 多层结构的 核仁 是 核糖体 生物合成的主要场所，在这里，构成核糖体小亚基 （SSU） 和大亚基 （LSU） 的 rRNA 前体 （ pre-rRNA ） 依次成熟。然而， pre-rRNA 加工与核仁亚结构之间的空间功能关系，以及这种关系如何适应细胞生理需求的变化，一直未被完全理解。 2025 年 7 月 23 日，中国科学院分子细胞科学卓越创新中心 陈玲玲 研究员团队 （博士生 潘宇航 、博士后 单琳 、博士生 张宇瑶 为共同第一作者） 在国际顶 尖学术期刊 Nature 上加速上线了题为： Pre-rRNA spatial distribution and functional organisation of the nucleolus 的研究论文。 该研究系统解析了构成核糖体大小亚基的 rRNA 前体 （ pre-rRNA ） 在核仁中的动态成熟过程，发现了核糖体小亚基 （ SSU ） pre-rRNA 的加工效率直接调 控核仁内层结构的稳定性，提出了 pre-rRNA 加工的区域化模 型 及其在多层结构核仁的功能与进化中具有重要意义 。 真核细胞的细胞核中的 ...